← SynDRA
LOBELINE
SynDRA canonical compound SYN0004430 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | SLC18A2 |
| Mechanism of action | Acetylcholine receptor antagonist |
| Indication | smoking cessation |
| Disease area | neurology/psychiatry |
All known targets
- SLC18A2
- CHRNA10
- CHRNA4
- CHRNA9
- CHRNB2
- OPRM1
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- SLC18A2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CHRNA7
- CYP2D6
- HTR2A
- ALOX15B
- MPHOSPH8
- UNG
- TDP1
- TDG
- SMUG1
- SLCO1B3
- SLCO1B1
- POLI
- OGG1
- NTHL1
- NEIL1
- METTL3
- MPG
- ARSA
- LMNA
- KCNH2
- HRH1
- HDAC6
- GMNN
- FEN1
- EHMT2
- CBX1
- ATXN2
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Ganglionic Stimulants
- Nicotinic Agonists
- Respiratory System Agents
Cross-references
Synonyms
- Lobelina
- (-)-lobeline
- .alpha.-lobeline
- Alpha-lobeline
- Inflatine
- Lobelinum
- NSC-757421
- Lobelin
- Lobeline [INN]
- Lobelinum [INN-Latin]
- Lobelina [INN-Spanish]
- EINECS 202-012-3
- BRN 0091533
- AC1LEL62
- ZINC56446
- Ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, (2R-(2alpha,6alpha(S*)))-
- LS-88107
- (-)-Lobeline
- alpha-Lobeline
- Lobnico
- 8,10-Diphenyllobelionol
- D0P25S3P81
- NSC 757421
- DTXCID603219
- CHEBI:48723
- RefChem:153874
- .alpha.-Lobeline
- Lobeline (INN)
- NCGC00024378-05
- Lobeline [INN:BAN]
- UNII-D0P25S3P81
- SR-01000075960
- L0B
- Lobeline alpha (-)
- NSC36866
- LOBELINE [MI]
- LOBELINUM [HPUS]
- Prestwick0_000585
Look up LOBELINE in the interactive SynDRA portal →